Sending Office: Honorable David Scott
Sent By:
Ijeoma.Egekeze@mail.house.gov

        Request for Cosponsor(s)

Support Uterine Fibroid Awareness Month

 

Cosponsors: Rep. Robin Kelly*, Rep. Marcia Fudge*, Rep. Lisa Blunt Rochester*

 

Dear Colleague:

I urge you to join me in recognizing July 2019 as Uterine Fibroid Awareness Month.

Uterine fibroids affect millions of American women and represent one of the most prevalent reproductive health issues in our nation. Research has shown that African American and Latina women are disproportionately impacted by uterine fibroid tumors. Unfortunately,
this issue has not received the attention, or funding, it deserves.

Increasing awareness about uterine fibroids is critical to our efforts to address the national maternal mortality crisis and prevent pregnancy-related deaths. Uterine fibroids are non-cancerous tumors that have been associated with increased rates of pregnancy
complications[i], including pre-term labor, postpartum hemorrhage, and miscarriage.

Pregnant women with uterine fibroids are more likely to need emergency C-sections[ii], and without access to quality prenatal care, many women who have uterine fibroids are not diagnosed[iii].
Women living with uterine fibroids often suffer with symptoms for longer periods of time and struggle to find qualified, experienced physicians who are familiar with this condition.

A study published in the American Journal of Obstetrics and Gynecology suggests that between 80 percent of African-American and 70 percent of White women will develop uterine fibroids[iv] by age 50.
Hospitalization rates for uterine fibroids are three times higher for African American women, and twice as high for Latina women, compared with women of other racial and ethnic backgrounds. However, the exact number of affected women is unknown because it
is difficult for healthcare providers to detect and accurately diagnose this condition. Only one-third of women living with uterine fibroids experience symptoms.

I ask you to join me in recognizing July 2019 as Uterine Fibroid Awareness Month to help highlight this important, yet overlooked, women’s health issue. If you would like to cosponsor this resolution (H.Res. 488), please contact Ijeoma Egekeze in my office
at ijeoma.egekeze@mail.house.gov.

Sincerely,

 

David Scott                                                                                                   

Member of Congress                                                                                    

 

 


[i] Lee, H. J., Norwitz, E. R., & Shaw, J. (2010). Contemporary management of fibroids in pregnancy. Reviews in Obstetrics and Gynecology3(1), 20.

[ii] Cardozo, E. R., Clark, A. D., Banks, N. K., Henne, M. B., Stegmann, B. J., & Segars, J. H. (2012). The estimated annual cost of uterine leiomyomata in the United States. American Journal of Obstetrics
and Gynecology
206(3), 211-e1.

[iii] Cardozo, E. R., Clark, A. D., Banks, N. K., Henne, M. B., Stegmann, B. J., & Segars, J. H. (2012). The estimated annual cost of uterine leiomyomata in the United States. American Journal of Obstetrics
and Gynecology
206(3), 211-e1.

[iv] Eltoukhi, H. M., Modi, M. N., Weston, M., Armstrong, A. Y., & Stewart, E. A. (2014). The health disparities of uterine fibroid tumors for African American women: a public health issue.
American Journal of Obstetrics and Gynecology, 210(3), 194-199.

Related Legislative Issues

Selected legislative information: HealthCare

Related Bill Information

Bill Type: H.Res.
Bill Type: 488
Special Note:

icon eDC logo e-Dear Colleague version 2.0
 
e-Dear Colleagues are intended for internal House use only.